Covera Health, an NYC-based tech firm specializing in AI-driven diagnostics, secured an additional up to $50 million in Series C funding. Insight Partners spearheaded the financing, which notably includes a previously committed $25 million. This capital boost aligns with Covera's strategic acquisition of CoRead, marking a significant extension of its diagnostics reach across over 2,000 US hospitals. By leveraging these funds, Covera is poised to advance diagnostic accuracy and patient care quality.